Array BioPharma To Present At The Stifel 2015 Healthcare And Jefferies 2015 Global Healthcare Conferences

Nov 09, 2015, 17:23 ET from Array BioPharma Inc.

BOULDER, Colo., Nov. 9, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.  

 

Event:          

Stifel 2015 Healthcare Conference

Date:            

Tuesday, November 17, 2015

Time:            

2:15 p.m.  Eastern Standard Time

Location:      

New York Palace Hotel, New York City

Event:            

Jefferies 2015 Global Healthcare Conference

Date:              

Thursday, November 19, 2015

Time:             

3:20 p.m.  Greenwich Mean Time

Location:        

London, England

 

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

 

CONTACT:

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com

 

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com